Franco Fais
Overview
Explore the profile of Franco Fais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bagnara D, Mazzarello A, Cardente N, Vergani S, Kasar S, Fernandes S, et al.
Haematologica
. 2025 Feb;
PMID: 39973373
Although chronic lymphocytic leukemia (CLL) is diagnosed by identifying a circulating B-cell clone that exceeds 5x106/μL, additional distinct clones (ADC) have been identified in various studies. Notably, the numbers of...
2.
Nano E, Reggiani F, Amaro A, Monti P, Colombo M, Bertola N, et al.
Noncoding RNA
. 2024 Sep;
10(5).
PMID: 39311383
A "watch and wait" strategy, delaying treatment until active disease manifests, is adopted for most CLL cases; however, prognostic models incorporating biomarkers have shown to be useful to predict treatment...
3.
Mazzarello A, Gugiatti E, Cossu V, Bertola N, Bagnara D, Carta S, et al.
Cancer Immunol Immunother
. 2024 Jan;
73(2):27.
PMID: 38280019
Chronic lymphocytic leukemia (CLL) is a disease of the elderly, often presenting comorbidities like osteoporosis and requiring, in a relevant proportion of cases, treatment with bisphosphonates (BPs). This class of...
4.
Giannoni P, Marini C, Cutrona G, Sambuceti G, Fais F, de Totero D
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894425
Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in Western countries. Although characterized by the progressive expansion and accumulation of leukemic B cells in peripheral blood, CLL cells develop...
5.
6.
Agathangelidis A, Ferrarini M, Fais F
Front Oncol
. 2023 Apr;
13:1188375.
PMID: 37035146
No abstract available.
7.
Giannoni P, Marini C, Cutrona G, Todoerti K, Neri A, Ibatici A, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497460
Significant skeletal alterations are present in Chronic Lymphocytic Leukemia (CLL) patients; bone erosion, particularly evident in the long bone shaft, appeared increased in the progressive disease stage. Moreover, the partial...
8.
Bagnara D, Mazzarello A, Ghiotto F, Colombo M, Cutrona G, Fais F, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430731
The engagement of the B cell receptor (BcR) on the surface of leukemic cells represents a key event in chronic lymphocytic leukemia (CLL) since it can lead to the maintenance...
9.
De Luca G, Cerruti G, Lastraioli S, Conte R, Ibatici A, Di Felice N, et al.
Hematol Oncol
. 2022 Aug;
40(5):962-975.
PMID: 35961859
Chronic lymphocytic leukemia (CLL) is a hematological disorder with complex clinical and biological behavior. TP53 mutational status and cytogenetic assessment of the deletion of the corresponding locus (17p13.1) are considered...
10.
Bagnara D, Colombo M, Reverberi D, Matis S, Massara R, Cardente N, et al.
Front Oncol
. 2022 Jul;
12:894419.
PMID: 35837088
Chronic Lymphocytic Leukemia (CLL) is characterized by the accumulation of monoclonal CD5 B cells with low surface immunoglobulins (IG). About 40% of CLL clones utilize quasi-identical B cell receptors, defined...